First Mercantile Trust’s BioAtla BCAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$34K Sell
23
-2
-8% -$3.9K ﹤0.01% 798
2021
Q2
$53K Buy
+25
New +$56.5K 0.01% 792
2021
Q1
Sell
-6
Closed -$10K 846
2020
Q4
$10K Buy
+6
New +$10K ﹤0.01% 845

Other funds holding BCAB

First Mercantile Trust's BCAB Position: Q3 2021 in Review

First Mercantile Trust reduced its BioAtla (BCAB) stake by 8% in Q3 2021, selling an estimated $3.9K and leaving 23 shares worth $34K. The position accounts for ﹤0.01% of the portfolio, ranked #798.

First Mercantile Trust first reported a position in BCAB in Q4 2020 and has held it in 3 quarters since. The position peaked at $53K in Q2 2021. 86 funds tracked by Wall St. Rank hold BCAB as of Q3 2021.

  • First Mercantile Trust held 23 shares of BioAtla worth $34K as of Q3 2021.
  • First Mercantile Trust sold 2 BioAtla shares in Q3 2021, an estimated $3.9K.
  • BioAtla made up ﹤0.01% of First Mercantile Trust's portfolio in Q3 2021, its #798 holding.
  • First Mercantile Trust first reported a position in BioAtla in Q4 2020 and has held it in 3 quarters since.
  • First Mercantile Trust's BioAtla position peaked at $53K in Q2 2021.
  • 86 funds tracked by Wall St. Rank held BioAtla as of Q3 2021.

Based on First Mercantile Trust's 13F filing for Q3 2021, filed 24 Nov 2021.